We are live on ! Find out more
KIA

KCM Investment Advisors Portfolio holdings

AUM $3.01B
1-Year Est. Return 21.97%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+21.97%
3 Year Est. Return
+71.25%
5 Year Est. Return
+89.24%
10 Year Est. Return
+291.31%
AUM
$2.79B
AUM Growth
+$78.9M
Cap. Flow
-$12.2M
Cap. Flow %
-0.44%
Top 10 Hldgs %
33.62%
Holding
382
New
6
Increased
125
Reduced
154
Closed
15

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$7.22M
2
CLX icon
Clorox
CLX
+$3.19M
3
MDT icon
Medtronic
MDT
+$3.05M
4
PCAR icon
PACCAR
PCAR
+$1.9M
5
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 19.31%
2 Consumer Staples 8.3%
3 Healthcare 7.4%
4 Consumer Discretionary 7%
5 Industrials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNDX icon
201
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
$1.12M 0.04%
50,127
IYF icon
202
iShares US Financials ETF
IYF
$4.61B
$1.09M 0.04%
11,564
-486
-4% -$45.5K
XYL icon
203
Xylem
XYL
$28.1B
$1.08M 0.04%
7,944
-1,245
-14% -$169K
PFF icon
204
iShares Preferred and Income Securities ETF
PFF
$13.3B
$1.07M 0.04%
33,895
+3,617
+12% +$114K
VB icon
205
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$1.06M 0.04%
4,880
ISRG icon
206
Intuitive Surgical
ISRG
$134B
$1.06M 0.04%
2,373
-45
-2% -$17.9K
TROW icon
207
T. Rowe Price
TROW
$24.3B
$1.05M 0.04%
9,146
-1,088
-11% -$125K
IOO icon
208
iShares Global 100 ETF
IOO
$9.25B
$1.05M 0.04%
10,872
NVS icon
209
Novartis
NVS
$297B
$1.05M 0.04%
9,824
-204
-2% -$20.5K
VRSK icon
210
Verisk Analytics
VRSK
$25B
$1.01M 0.04%
3,750
-29
-0.8% -$7.1K
ENPH icon
211
Enphase Energy
ENPH
$5.53B
$995K 0.04%
9,982
+995
+11% +$116K
XNTK icon
212
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$972K 0.03%
4,977
-8
-0.2% -$1.47K
SMH icon
213
VanEck Semiconductor ETF
SMH
$73.2B
$971K 0.03%
3,724
SCHX icon
214
Schwab US Large- Cap ETF
SCHX
$74.5B
$962K 0.03%
44,934
BMY icon
215
Bristol-Myers Squibb
BMY
$132B
$954K 0.03%
22,978
-2,375
-9% -$106K
VOO icon
216
Vanguard S&P 500 ETF
VOO
$1.01T
$911K 0.03%
1,821
+52
+3% +$25K
IGV icon
217
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
$911K 0.03%
10,480
+130
+1% +$10.7K
A icon
218
Agilent Technologies
A
$41.2B
$893K 0.03%
6,890
-803
-10% -$112K
TEAM icon
219
Atlassian
TEAM
$37.8B
$876K 0.03%
4,950
+2,570
+108% +$459K
STZ icon
220
Constellation Brands
STZ
$23.2B
$856K 0.03%
3,326
+1
+0% +$257
ASML icon
221
ASML
ASML
$669B
$848K 0.03%
829
FITB
222
Fifth Third Bancorp
FITB
$51.8B
$843K 0.03%
23,089
-12,478
-35% -$456K
VLO icon
223
Valero Energy
VLO
$85.9B
$830K 0.03%
5,293
MCK icon
224
McKesson
MCK
$101B
$827K 0.03%
1,416
+61
+5% +$34K
BDX icon
225
Becton Dickinson
BDX
$48.7B
$809K 0.03%
3,460
+30
+0.9% +$7.07K

Similar funds

KCM Investment Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, KCM Investment Advisors held 382 positions worth $2.79B, up 2.9% from $2.71B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

KCM Investment Advisors's Q2 2024 filing shows 6 new, 125 increased, 154 reduced and 15 closed positions. Its largest new stake was TE Connectivity: 12,588 shares worth $1.89M. The largest sale was Labcorp, an estimated $7.22M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Healthcare.

  • KCM Investment Advisors's largest Q2 2024 buy was TE Connectivity: 12,588 shares worth $1.89M.
  • KCM Investment Advisors added most to Southern Copper in Q2 2024, an estimated $3.9M increase.
  • KCM Investment Advisors's biggest Q2 2024 reduction was Clorox, cutting an estimated $3.19M.
  • KCM Investment Advisors fully exited Labcorp in Q2 2024, selling an estimated $7.22M.
  • KCM Investment Advisors's ten largest holdings make up 34% of its $2.79B portfolio in Q2 2024.
  • KCM Investment Advisors opened 6 new positions and closed 15 in Q2 2024.
  • KCM Investment Advisors's portfolio value rose 2.9% quarter-over-quarter to $2.79B.

Based on KCM Investment Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.